bims-scepro Biomed News
on Stem cell proteostasis
Issue of 2026–09–20
twenty-two papers selected by
William Grey, University of York



  1. Blood. 2026 Sep 17. pii: blood.2026034181. [Epub ahead of print]
      Targeting metabolic dependencies of leukemic stem cells (LSC) may open avenues to improve outcomes of patients suffering from acute myeloid leukemia (AML). LSCs rely heavily on an active tricarboxylic acid (TCA) cycle and mitochondrial oxidative phosphorylation whereas healthy hematopoietic stem and progenitor cells (HSPCs) possess more metabolic flexibility. Here, we identify the TCA cycle enzyme isocitrate dehydrogenase 3 (IDH3) as a critical and selective regulator of LSC maintenance. IDH3 is more abundant in LSCs compared to healthy HSPCs, and TCA cycle activity correlates with inferior clinical outcomes of AML patients. Knockdown of IDH3A, the catalytic subunit of the complex, impairs colony-forming potential and bone marrow organoid as well as in vivo engraftment of AML, while sparing healthy hematopoiesis. Mechanistically, IDH3A downregulation reduces TCA cycle flux and leads to accumulation of intracellular citrate, impairing both glycolysis and oxidative phosphorylation. The resulting bioenergetic crisis activates AMPK and suppresses mTORC1, leading to reduced translational activity and an imbalance of anti-apoptotic proteins. Consequently, IDH3A-KD cells show enhanced susceptibility to BCL2 inhibition by venetoclax in vitro and in vivo. In a clinical cohort, LSCs from patients resistant to venetoclax/azacitidine (Ven/Aza) exhibit transcriptomic programs indicative of active TCA cycle and glycolysis. We demonstrate that downregulation of IDH3A activity and subsequent citrate accumulation directly affect these pathways and shift AML stem cells towards a metabolic state of increased vulnerability. In summary, we establish IDH3 as a metabolic rheostat in LSCs and suggest targeting the IDH3A-citrate axis to overcome Ven/Aza resistance of AML patients.
    DOI:  https://doi.org/10.1182/blood.2026034181
  2. Redox Biol. 2026 Sep 12. pii: S2213-2317(26)00395-2. [Epub ahead of print]97 104396
      Aging reshapes hematopoiesis toward myelopoiesis, particularly increased output of classical monocytes, contributing to immunosenescence. However, the underlying mechanisms remain unclear. Here, we identify that aging drives hematopoietic stem cells (HSCs) to progressively commit to a CCR2+ monocyte fate along a defined lineage trajectory, which is executed through a redox-sensitive transcriptional cascade. We find that the age-related decline in bone marrow IGF-1 is the upstream niche signal that releases suppression of the oxidative stress/NF-κB/IRF8 axis, allowing this cascade to redirect early progenitors toward a CCR2+ myeloid-primed fate. Functional assays confirm that cells following this CCR2+ trajectory drive myeloid-biased hematopoiesis and directly contribute to age-associated immunosuppression. Our work delineates a hierarchical pathway from niche decay to lineage redirection, establishing the CCR2+ fate trajectory as a key driver of immunosenescence and a potential therapeutic target.
    Keywords:  CCR2; IGF-1; Immunosenescence; Immunotherapy; Redox signaling
    DOI:  https://doi.org/10.1016/j.redox.2026.104396
  3. Nat Genet. 2026 Sep 15.
      Inflammation accelerates evolutionary dynamics of hematopoietic stem cells (HSCs) in clonal hematopoiesis and myeloid neoplasms. We studied HSCs, progenitors and immune cells from patients with myeloproliferative neoplasms at baseline and following interferon-α (IFNα) treatment, the only therapy to deplete mutated stem cells. We deployed single-cell multiomics methods that distinguish the IFNα effects on mutated stem cells from the admixed wild-type HSCs, with respect to their differentiation, transcriptomes, immunophenotypes and chromatin accessibility. IFNα simultaneously activated HSCs into two polarized states: a lymphoid progenitor expansion associated with an anti-inflammatory state and an inflammatory myeloid progenitor state derived from HSCs. The augmented lymphoid differentiation balanced the typical myeloproliferative-neoplasm-induced myeloid bias, associated with normalized blood counts. Somatic mutations modified the effects of IFNα on HSC differentiation and cell cycle entry rates. Clonal fitness upon IFNα exposure was due to resistance of CALR- or JAK2-mutated stem cells to differentiate into inflammatory myeloid progenitors.
    DOI:  https://doi.org/10.1038/s41588-026-02751-3
  4. Nat Commun. 2026 Aug 07. pii: 9765. [Epub ahead of print]17(1):
      Hematopoietic stem and progenitor cells (HSPCs) sustain blood production through tightly regulated fate decisions. Disruption of this control underlies disorders such as myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and inherited thrombocytopenias. While transcriptional and epigenetic regulation of HSPCs is well established, the contribution of glycosylation has remained largely unexplored. Here, we identify the glycosyltransferase B4GALT1 as a central regulator of hematopoiesis that integrates extrinsic niche cues with intrinsic transcriptional programs. B4GALT1 shapes the bone marrow microenvironment by generating complex glycan niches that support HSPC function. However, its deficiency produces oncogenic glycan signatures, disrupts HSPC niche integrity, and induces aberrant expression of Mucin 13 (MUC13). These changes expand stem and progenitor pools, enforce megakaryocyte lineage bias, and activate the Wnt-MUC13/β-catenin signaling axis, a pathway tightly linked to proliferation and malignant transformation. Consequently, B4GALT1 loss uncouples proliferation from self-renewal, altering key regulators of stem cell quiescence, lineage balance, and marrow homeostasis. Our findings define a previously unrecognized glycan-dependent regulatory axis that directs HSPC fate through coordinated transcriptional reprogramming, signaling modulation, and niche remodeling. This work establishes aberrant glycosylation as a driver of hematopoietic dysfunction and highlights B4GALT1 as a potential therapeutic target in stem cell-driven blood disorders.
    DOI:  https://doi.org/10.1038/s41467-026-76246-4
  5. Cell Rep. 2026 Sep 18. pii: S2211-1247(26)01102-2. [Epub ahead of print]45(10): 118024
      Hematopoietic stem and progenitor cells (HSPCs) arise from hemogenic endothelial cells (HECs) via the endothelial-to-hematopoietic transition (EHT). As a signature gene of hematopoietic stem cell-primed HECs, Mycn is highly expressed in these cells alongside its paralog, Myc. However, their roles and underlying mechanisms in EHT remain unclear. Here, we demonstrate that endothelial-specific deletion of Mycn, but not Myc, impairs HSPC formation in mouse embryos. Single-cell transcriptomics and functional assays reveal that Mycn deficiency specifically attenuates the HEC-to-HSPC transition but not thereafter. We also establish a mosaic analysis strategy to distinguish Mycn deletion states in mutant embryos, enabling precise characterization. Unlike control HECs that downregulate adhesion signatures during their specification, Mycn-deficient HECs aberrantly upregulate adhesion pathways. Inhibiting focal adhesion kinase, a critical modulator of cell adhesion, rescues HSPC production in Mycn-deficient explant cultures. These findings uncover a regulatory mechanism whereby Mycn promotes HSPC generation from endothelial cells by suppressing adhesion signaling.
    Keywords:  CP: cell biology; CP: stem cell research; Mycn; cell adhesion; endothelial-to-hematopoietic transition; hematopoietic development; hematopoietic stem cells; hemogenic endothelial cells
    DOI:  https://doi.org/10.1016/j.celrep.2026.118024
  6. Nat Commun. 2026 09 16. pii: 9877. [Epub ahead of print]17(1):
      Cellular senescence is a state of irreversible cell cycle arrest triggered by telomere erosion, persistent DNA damage or chronic stress. The accumulation of senescent cells disrupts tissue function and contributes to aging and disease. Here, we employ mass spectrometry-based proteomics to systematically interrogate dynamic proteome changes at multiple levels during the progression of replicative cellular senescence. We demonstrate that proteome changes during senescence occur in a coordinated manner, characterized by widespread protein depletion on chromatin. Moreover, components of the cytoplasmic translation machinery are depleted, while mitochondrial proteins display increased insolubility. Autophagic and proteasome activity is compromised in senescent cells along with remodeling of ubiquitin linkages and depletion of ubiquitin E3 ligases. Comparison of the senescent proteome with different pathophysiological cellular states reveals a distinctive senescent signature shaped by changes in the proteostasis network. Collectively, we provide a resource for the exploration of temporally resolved changes in the senescent proteome.
    DOI:  https://doi.org/10.1038/s41467-026-77686-8
  7. J Immunother. 2026 Sep 14.
      Acute myeloid leukemia (AML) is a hematological malignancy associated with poor prognosis. Recent developments in natural killer (NK) cell-based immunotherapies have resulted in the robust expansion of NK cells with enhanced cytotoxicity against hematological malignancies. However, disease relapse remains a challenge. Another therapeutic intervention that has garnered high interest is the use of lysine-specific demethylase 1 (LSD1) inhibitors for AML treatment. Here, we investigated whether LSD1 inhibition could synergize with ex vivo expanded NK (exNK) cells in a primary AML sample. Interestingly, we observed that treatment with the LSD1 inhibitors, bomedemstat and GSK-LSD1, led to the upregulation of multiple stress ligands known to activate NK cells. Importantly, this increased stress ligand expression was associated with enhanced NK cell-mediated cytotoxicity, suggesting the potential for both therapies to be used synergistically. To our knowledge, this is the first study to assess the combination of LSD1 inhibition and exNK cells in AML.
    Keywords:  LSD1 inhibition; NK cell immunotherapy; acute myeloid leukemia; natural killer cells
    DOI:  https://doi.org/10.1097/CJI.0000000000000618
  8. Stem Cell Res. 2026 Sep 11. pii: S1873-5061(26)00196-0. [Epub ahead of print]96 104100
      Mesenchymal stromal cells (MSCs) are key components of the bone marrow (BM), providing structural support and paracrine signals that regulate haematopoietic stem cell maintenance, self-renewal and differentiation. However, primary BM MSCs are rare, heterogeneous, and subject to donor variability and have limited ex-vivo expansion capacity, restricting their utility. Here, we describe two human induced pluripotent stem cells lines, CRICKi0025-A and CRICKi0026-A, reprogrammed from adult BM-derived MSCs using non-integrating Sendai virus vectors. Both lines showcase grade-A morphology, are genomically stable, upregulate essential pluripotent markers and can differentiate into the three germ layers. These lines are a well-characterised resource for generating MSCs.
    DOI:  https://doi.org/10.1016/j.scr.2026.104100
  9. Cancer Discov. 2026 Sep 15.
      Acute Myeloid Leukemia (AML) is characterized by significant immunosuppression, limiting the efficacy of immunotherapy. Monocytic AML presents unique immunosuppressive features and constitutes a challenging subtype necessitating focused investigation. Using single-cell multi-omics analyses of primary AML samples, we revealed the immunosuppression landscape of monocytic AML and identified BLVRB as a marker of immunosuppressive monocytic AML cells. BLVRB depletion downregulated immune-modulatory gene expression and sensitized AML cells to T cell cytotoxicity, resulting in improved therapeutic efficacy in cell line and patient-derived xenograft models. Mechanistically, BLVRB signals through the transcription factor MAFB to masterfully promote the expression of various immunosuppression-associated genes, resulting in inhibitory effect against anti-AML T cells. We further demonstrated that the small molecule Tamibarotene targets BLVRB, enhancing the efficacy of both CAR-T and anti-PD-1 antibody therapies in AML. These findings elucidate the critical mechanism regulating immunosuppression in monocytic AML and identify BLVRB as a therapeutic target for improving AML immunotherapy.
    DOI:  https://doi.org/10.1158/2159-8290.CD-26-0447
  10. Curr Top Dev Biol. 2026 ;pii: S0070-2153(26)00081-5. [Epub ahead of print]170 1-48
      Hematopoiesis is governed by precisely coordinated transcriptional programs that balance hematopoietic stem cell (HSC) self-renewal with the ability to differentiate into multiple blood lineages. During normal hematopoiesis, cells maintain tight control over the level of ribosomal RNA (rRNA) transcription by RNA Polymerase I (Pol I) and over mature rRNA abundance (ribosomal subunits). Although the factors governing RNA Polymerase II (Pol II)-mediated gene expression and their roles in cell fate determination are well characterized, far less is known about the regulation of rRNA transcription and ribosome abundance. Little is known also about how ribosome numbers contribute to hematopoietic cell fate. This review summarizes current literature on the mechanisms by which hematopoietic cell types fine-tune rRNA transcription and ribosomal subunit abundance throughout cell fate trajectories, and how dysregulation of these processes contributes to acute myeloid leukemia (AML).
    Keywords:  Hematopoiesis; Leukemia; Nucleolus; RNA polymerase I (Pol I); Ribosomal DNA (rDNA); Ribosomal RNA (rRNA); Ribosome biogenesis; Ribosomes; rRNA transcription
    DOI:  https://doi.org/10.1016/bs.ctdb.2026.06.008
  11. Curr Top Dev Biol. 2026 ;pii: S0070-2153(26)00074-8. [Epub ahead of print]170 125-156
      Red blood cells constitute over 99 % of all blood cells and 2-3 million erythrocytes are generated every second in human body. The process of generating red blood cells, erythropoiesis, is tightly regulated at the multiple levels of the hematopoietic hierarchy to fulfil this intensive demand for oxygen carrying cells. Recent studies uncovered that lineage specification begins at the multipotent stages such as hematopoietic stem cell (HSC) and multipotent progenitor (MPP) populations. In this review, we discuss lineage-biased HSCs and MPPs, the erythroid linage bias in HSCs and MPPs, how erythroid fate decisions are made in common myeloid progenitors (CMPs) and megakaryocyte-erythroid progenitors (MEPs), and what alters erythroid lineage commitment in aging and disease conditions.
    Keywords:  Cytokines; Erythroid lineage specification; Fate decision mechanisms; Lineage-biased hematopoietic stem cells; Lineage-biased multipotent progenitors; Transcription factors
    DOI:  https://doi.org/10.1016/bs.ctdb.2026.06.001
  12. JCI Insight. 2026 Sep 15. pii: e205218. [Epub ahead of print]
      Cell metabolic rewiring is associated with resistance to venetoclax-azacitidine (Ven-Aza) combination therapy and relapse in acute myeloid leukemia (AML) patients. Drug-resistant cells exhibit an enhanced reliance on oxidative phosphorylation (OXPHOS) for energy production. Therefore, impairing mitochondrial metabolism represents an exciting strategy to face this unmet clinical need. We recently demonstrated that the specific activation of the phosphatase PP2A-B56α enhances the pro-apoptotic efficacy of venetoclax in AML. Here, through leveraging unbiased multi-omics-based approaches and using both genetic and pharmacological tools, we define key roles for the tumor suppressor PP2A-B56α complex in OXPHOS regulation and treatment response in disease-relevant AML models. From a translational perspective, the specific stabilization of PP2A-B56α heterocomplex with the novel PP2A molecular glue activator, RPT04402, reduces OXPHOS levels in treatment-resistant AML cells and improves treatment response in both Ven-Aza-sensitive and -resistant AML cell lines, primary cells, and in vivo models. Together, our work supports further research on targeted combination therapy approaches based on PP2A-B56α stabilization to counteract OXPHOS-related treatment resistance and improve AML responses in a patient population with historically poor outcomes.
    Keywords:  Cell biology; Drug therapy; Hematology; Phosphoprotein phosphatases; Tumor suppressors
    DOI:  https://doi.org/10.1172/jci.insight.205218
  13. Ann Lab Med. 2026 Sep 17.
       Background: Public cord blood (CB) banks provide essential hematopoietic stem cell sources for patients without matched donors. With haploidentical and haplo-cord transplantation expanding, reassessing CB banking quality and efficiency is increasingly important. We analyzed 20-yr operational data from Korea's largest public CB bank to identify quality trends and predictive factors for banking success.
    Methods: We retrospectively analyzed CB units processed at a single public CB bank across three regulatory phases: phase 1 (pre-Act, 05/2006-06/2011), phase 2 (07/2011-12/2020), and phase 3 (Act Amendment, 01/2021-12/2025). Multiple linear regression with mean-centered predictors and multivariable logistic regression with bootstrap validation were used to identify factors influencing pre-processing total nucleated cell (TNC) count and banking outcome, respectively.
    Results: Of 73,925 units, 27,684 (37.4%) were banked. Banking rates declined from 35.6% to 24.8% across phases, while post-processing TNC in banked units increased from 10.08 to 11.87×108 and TNC recovery from 74.4% to 85.6% (all pairwise P <0.001). Collection volume was the strongest pre-processing TNC count predictor. Pre-processing TNC count and TNC recovery were the primary banking determinants. Caesarean section lowered pre-processing TNC count but independently improved banking odds. Delivery hospital effects were significant in both regression analyses (P <0.001).
    Conclusions: Quality metrics improved across regulatory phases despite declining banking rates. Collection volume, delivery mode, and hospital-level variation are key modifiable factors. Standardized collection protocols and collector education are warranted to optimize CB banking efficiency.
    Keywords:  Cord blood banking; Hematopoietic stem cell transplantation; Public cord blood bank; Quality management; Total nucleated cell count
    DOI:  https://doi.org/10.3343/alm.2026.0169
  14. Colloids Surf B Biointerfaces. 2026 Sep 10. pii: S0927-7765(26)00742-3. [Epub ahead of print]269 116154
      Acute myeloid leukemia (AML) cells can be protected from chemotherapy through CXCR4-associated interactions with the bone marrow microenvironment and adaptive redox buffering. Here, we developed CTCE-9908-functionalized, cytarabine (Ara-C) and the CXCR4 antagonist AMD3100-coloaded liposomes (C-AM@Lipo) for integrating CXCR4-directed uptake enhancement with redox-associated chemosensitization. CTCE-9908 functionalization increased cellular uptake in HL-60 and C1498 leukemia cells, while scrambled peptide modification and competitive inhibition reduced this advantage, supporting the involvement of CTCE-9908/CXCR4-associated interactions. Compared with free drugs and non-functionalized liposomes, C-AM@Lipo induced greater apoptosis and more pronounced redox disturbance, characterized by reduced GSH/GSSG ratios, increased mitochondrial superoxide generation, lipid peroxidation, and γH2AX-associated DNA damage. In a disseminated C1498-Luc-GFP leukemia model, C-AM@Lipo reduced systemic and bone marrow leukemia burden and prolonged survival. DiR-based biodistribution analysis showed enhanced femoral accumulation, while extended safety evaluation demonstrated preserved bone marrow cellularity and no evident hematological or hepatorenal toxicity. Collectively, this study establishes a coordinated liposomal strategy linking CXCR4-associated uptake enhancement with Ara-C/AMD3100 co-delivery and redox-associated chemosensitization for improved AML therapy.
    Keywords:  Acute myeloid leukemia; CXCR4; Cytarabine; Liposomal co-delivery; Redox homeostasis
    DOI:  https://doi.org/10.1016/j.colsurfb.2026.116154
  15. Cell Rep. 2026 Sep 16. pii: S2211-1247(26)01077-6. [Epub ahead of print]45(10): 117999
      Natural killer (NK) cells are key mediators of immune surveillance following hematopoietic stem cell transplantation (HSCT). However, despite the post-conditioning spike in interleukin-15 (IL-15), NK cell maturation is frequently delayed following HSCT. Here, we show that during in vitro NK cell development from CD34+ hematopoietic progenitor cells, early exposure to IL-15 drives aberrant mTOR activation, resulting in DNA methylation and transcriptional dysregulation with suppressed maturation and KIR acquisition. In contrast, transiently withholding IL-15 or inhibition of mTOR with rapamycin generates NK cell developmental intermediates intrinsically poised to mature into highly functional, KIR-expressing NK cells. Single-cell analysis of HSCT patients at early post-transplant time points reveals a similar aberrant transcriptional signature of IL-15/mTOR overactivation in circulating donor-derived NK cells. These findings identify a developmental window when IL-15 signaling can paradoxically subvert NK cell maturation and KIR acquisition, suggesting that temporally regulated cytokine signaling could accelerate immune reconstitution and improve therapeutic efficacy.
    Keywords:  CP: immunology; HSCT; IL-15; KIR; NK; NK cell development; hematopoietic stem cell transplant; interleukin-15; killer immunoglobulin-like receptor; mTOR; natural killer cell
    DOI:  https://doi.org/10.1016/j.celrep.2026.117999
  16. Nat Commun. 2026 09 16. pii: 9647. [Epub ahead of print]17(1):
      Efficient clearance and recycling of dysfunctional mitochondria through the robust catabolic activity of lysosomes are essential for cellular health. However, how membrane lipids contribute to maintaining the degradative capacity of lysosomes remains poorly understood. Here, we show that cholesterol plays a critical role in preserving the functional integrity of degradative lysosomes. Clearance of damaged mitochondria by degradative lysosomes is tightly coupled with the acute accumulation of phosphatidylinositol 4-phosphate (PI4P) on the lysosomal surface via PI4KIIα activity. This PI4P accumulation activates oxysterol-binding protein (OSBP)-mediated cholesterol transport from the endoplasmic reticulum (ER) to lysosomal membranes. The resulting efflux of cholesterol from the ER activates sterol regulatory element-binding protein 2 (SREBP-2), enhancing cholesterol production. Sustained cholesterol accumulation on lysosomal membranes maintains lysosomal acidity and membrane integrity for efficient mitochondrial degradation. This degradation process then leads to the release of free fatty acids and their recycling and storage through the formation of DGAT1-dependent lipid droplets. These findings uncover a key phosphoinositide-regulated cholesterol transport pathway that promotes the clearance and recycling of dysfunctional mitochondria, a process whose impairment is closely linked to neurodegeneration.
    DOI:  https://doi.org/10.1038/s41467-026-77423-1
  17. Nature. 2026 Sep 14.
      Each stage of the Central Dogma contributes to proteome diversity through mechanisms such as heterozygosity, somatic mutations, transcriptional errors, and translational errors. As a result, a diverse array of protein variants can coexist within a single proteome, such as that of humans. However, until now, methods to detect, quantify, and evaluate the functional consequences of these variants have been lacking. Here we examined a large-scale proteogenomic dataset from 29 healthy human tissues and uncovered 13,910 confidently localized variants representing 7,215 unique single amino acid substitutions co-existing alongside their corresponding reference proteoforms 1.We found that the abundance of both genetic (SNP's, somatic mutations) and mistranslated protein variants mirrors their allele frequencies in the human population. Moreover, we show that non-genetic substitutions may provide a distinct route for exploring protein sequence space, circumventing the mutational constraints imposed by the genetic code. In addition, we provide experimental validation of non-genetic substitution on selected purified proteins. We demonstrate specific and recurring non-genetic variation patterns upon amino acid starvation in proteome-wide analyses of cancer-derived cell lines and identify hundreds of substituted non-genetic proteoforms that recur consistently in multiple healthy individuals or map to annotated protein functional sites. We propose that these substitutions constitute a novel class of functional protein phenotypic variants. Collectively, our findings indicate that non-genetic amino acid substitutions in human proteins provide an abundant source to expanding the functional proteome.
    DOI:  https://doi.org/10.1038/s41586-026-11124-z
  18. Nature. 2026 Sep 16.
      Ferroptosis is a form of regulated cell death driven by iron-dependent lipid peroxidation and is implicated in diverse pathological states1-4. Although mitochondria and other organelles are increasingly being recognized as important modulators of ferroptosis5-7, a unifying mechanism that couples organelle dynamics to ferroptotic execution has remained elusive. Here using quantitative phosphoproteomics, we identified mitochondrial fission factor (MFF) as a key ferroptosis-selective regulator. Mechanistically, the lipid mediator 17-HETE promotes phosphorylation of MFF at Ser155, which triggers the coordinated fragmentation and dysfunction of mitochondria and peroxisomes. This remodelling intensifies interorganelle crosstalk, amplifies oxidative stress and accelerates ferroptotic death. To monitor this phosphorylation event in living cells, we developed MFF-SPARK, a phase-separation-based biosensor, for real-time tracking of ferroptosis through MFF activation. Using MFF-SPARK, we identified PKCβ and DUSP22 as a coordinated kinase-phosphatase pair that governs MFF phosphorylation. We also discovered avermectin B1 as a pharmacological activator of the PKCβ-MFF axis, which can sensitize tumours to ferroptosis in vivo. Together, our findings establish MFF phosphorylation as a central regulatory node in ferroptosis-associated organelle remodelling and provide a conceptual framework and toolbox for monitoring and pharmacologically interrogating ferroptosis.
    DOI:  https://doi.org/10.1038/s41586-026-11020-6
  19. J Pathol Inform. 2026 Nov;23 100710
       Background: Automated classification of hematopoietic cells presents unique challenges due to morphological overlap across maturation stages and interobserver variability. Whereas deep learning models have demonstrated promising performance in digital pathology, limited attention has been given to systematic interpretability analysis in hematological cytomorphology.
    Objective: To develop and rigorously evaluate an interpretability-centered deep learning framework for multiclass classification of 21 bone marrow cytomorphological cell types, incorporating cross-validation, formal statistical comparison of architectures, and multimodal visualization to assess both predictive performance and biological plausibility.
    Methods: We developed a multiclass deep learning framework using EfficientNet-B3 to classify 171,373 bone marrow single-cell images spanning 21 morphological categories. Model performance was evaluated using top-1 accuracy, top-5 accuracy, macro-F1, and weighted-F1 scores. To assess robustness, 5-fold stratified cross-validation was performed. EfficientNet-B3 was compared against ResNet50 and DenseNet121, with statistical significance assessed using McNemar's test and bootstrap confidence intervals. Interpretability was evaluated through Grad-CAM visualization of confusion pairs and SHAP-based feature attribution. Latent feature structure was examined using PCA, UMAP, and t-SNE projections.
    Results: On the held-out validation set, EfficientNet-B3 achieved top-1 accuracy of 87.6%, whereas cross-validated performance averaged 76.3% ± 0.27. Performance was statistically superior to both ResNet50 and DenseNet121, although the magnitude of improvement over DenseNet121 was modest. Most misclassifications occurred between morphologically adjacent classes, consistent with biological lineage continuity. Grad-CAM analysis demonstrated biologically plausible attention patterns in nuclear and cytoplasmic regions. Embedding projections revealed partial class clustering with expected overlap among transitional cell types.
    Conclusion: This study reframes deep learning-based hematopoietic classification as an interpretability-centered problem. By integrating cross-validation, statistical model comparison, and multimodal visualization, we provide a comprehensive framework for understanding both performance and failure modes in multiclass bone marrow cytomorphology classification. These findings support the role of explainable artificial intelligence as a decision-support tool in hematopathology rather than a standalone diagnostic system.
    Keywords:  Bone marrow cytomorphology; Cross-validation; Deep learning; Explainable artificial intelligence; Grad-CAM; Hematopathology; Multiclass classification; SHAP
    DOI:  https://doi.org/10.1016/j.jpi.2026.100710
  20. Cells. 2026 Aug 24. pii: 1521. [Epub ahead of print]15(17):
      Adult hematopoietic stem cells (HSCs) and bone marrow (BM) mesenchymal stem/stromal cells (MSCs) are essential for lifelong hematopoiesis, skeletal homeostasis, immune competence, and tissue regeneration. The use of electronic cigarettes (E-cigs) among women of reproductive age continues to rise, raising concerns about potential adverse developmental effects; however, the long-term consequences of maternal E-cig vaping on offspring BM stem cell function and hematopoietic homeostasis remain incompletely understood. Here, using a rat model of maternal E-cig exposure (containing nicotine) during gestation, combined with longitudinal in vivo analyses and complementary ex vivo studies of human cells, we show that prenatal E-cig exposure is associated with persistent alterations in offspring BM stem cell function and lineage commitment. Gestational E-cig exposure was associated with expansion of the CD11b/c+ myeloid-enriched compartment, increased CD90+ stromal cells, and impaired osteogenic differentiation in rat offspring. Complementary experiments using primary human cells showed that nicotine exposure was associated with reduced T-cell proliferation and impaired cytotoxic activity in a proof-of-principle co-culture assay. Mechanistically, transcriptomic profiling followed by Gene Ontology and pathway enrichment analyses identified alterations in molecular programs associated with KLF4-Notch1 signaling, mitochondrial biogenesis, inflammation, and stem cell regulation in the BM of E-cig-exposed rat offspring. Changes in CCL11, FTO, and RUNX2 were additionally associated with an inflammatory and aging-related molecular phenotype that persisted from early life into adulthood, although these findings do not establish a causal CCL11-FTO-RUNX2 signaling axis or direct cellular senescence. Collectively, our study provides a phenotypic and mechanistic framework for understanding how maternal E-cig exposure may influence long-term offspring hematopoietic, skeletal, and immune health while highlighting the need for further studies to establish causal molecular mechanisms and determine their relevance to maternal E-cig use in humans.
    Keywords:  FTO; KLF4; Notch1; RUNX2; epigenetics; hematopoietic stem cells; maternal vaping; mesenchymal stem/stromal cells; mitochondrion; nicotine
    DOI:  https://doi.org/10.3390/cells15171521
  21. Nat Metab. 2026 Sep 15.
      Thiol-containing metabolites are central to cellular redox homeostasis1. Among these, cysteine functions as a proteogenic amino acid, supports redox balance and iron-sulfur cluster biogenesis, and, when depleted, triggers ferroptosis2. Cells nevertheless maintain cysteine at low levels, reflecting its intrinsic toxicity, but the mechanisms by which excess cysteine causes cell death remain unclear3. Here we performed a genome-wide CRISPR screen and identified mitochondrial iron transporters as essential mediators of cysteine toxicity. Limiting mitochondrial iron availability suppresses cysteine-induced cell death and prevents impairment of iron-sulfur cluster proteins and respiration. Mechanistically, cysteine mobilizes iron from ferritin, expands the cytosolic iron pool and drives mitochondrial iron accumulation. Enhancing glutathione reductase activity specifically within mitochondria restores redox balance downstream of iron accumulation and protects cells by maintaining iron-sulfur cluster integrity. Our findings suggest that maintaining low cysteine levels safeguards mitochondrial iron homeostasis, and that excess cysteine triggers a distinct mitochondrial iron-dependent cell death under conditions of thiol imbalance.
    DOI:  https://doi.org/10.1038/s42255-026-01616-7